Mary B Sheppard, MD

Physician-scientist passionate about improving the lives of people with aortic disease
Co-Director Saha Aortic Center
UK College of Medicine

[nancyatheart @NancyatHeart]

With @POTUS' signature & funding included in the federal spending bill, the CAROL Act is now law. It will fund research & awareness of valvular heart disease & help prevent countless families from facing the same loss as the Barr family. @RepAndyBarr https://t.co/6A3Q2E4nfO

[USTiCR_UK_RPA @USTiCR_UK_RPA]

Throw back to the lunch enrichment on July 15th: @alan_daugherty talked about the way to improve rigor and reproductivity. @MaryBShep shared her journey of becoming a physician scientist. @PengjunWang and @Diksha_Satish13 shared about their current projects!
@UKYMedicine @UKUGR

[Edgardo Alania @Ed_Alania]

🟢Exercise in the Genetic Arrhtythmia Syndromes @OliverMonfredi

🟢Sports Participation and Physical Activity in individuals with Heritable Thoracic Aortic Disease and Aortopathy Conditions @MaryBShep

🟢Cardiac Concerns in the Pediatric Athlete @JamieColombo1

#Cardiology

[Alan Daugherty @alan_daugherty]

https://t.co/geAjClWLUD

[Sterling C. Torian @sterlingtorian]

To the resident who ended the phone call about a drug dosing question with “Ok love you bye” and immediately messaged me sorry in embarrassment — I hope you know that you absolutely made my day, I cannot stop laughing about it, & I understand your sleep deprivation #residency

[Justin F. Fraser, MD @Doctorjfred]

Just got a Cameo from Dr. Glaucomflecken@dglaucomflecken #cameofameo https://t.co/l8uGNEhNKv Coolest birthday present ever! Thanks to my loving wife and to Dr G himself!

[Kathryn Moore Lab @KathrynMooreLab]

Honored to receive the Gill Heart and Vascular Institute Award for Outstanding Contributions to Cardiovascular Research. Can’t wait to visit @GillKentucky in person! @NYUCVRC

[Scott LeMaire @scottlemaire]

Another set of beautiful illustrations by @Scott_A_Weldon!
@BCM_CTSurgery
@BCM_Surgery

[Nature Cardiovascular Research @NatureCVR]

Online today, a study by Nicholas Leeper’s team shows that #statins reduce the “‘don’t-eat-me” molecule #CD47 thus amplify #macrophages #phagocytic capacity and amplify the effect of pro-#efferocytic therapies in #atherosclerosis @StanfordMed | https://t.co/IZSge6pVlU

[Sam Tyagi, MD @SamTyagiMD]

It was great to attend the 2022 Central Kentucky ❤️ Heart Ball! 🥃 tasting, live and silent auctions, inspiring speech by @Work_Horse68, all for a great cause! @GillKentucky @American_Heart @UKvascular #sahacvrc @alan_daugherty

[Eric Green @NHGRI_Director]

An entire genome contains around 6 billion individual building blocks, and we can now read the order of those building blocks in a day for less than $1,000! Improvements in sequencing technologies since the Human Genome Project have led to advances in the study of human diseases.

[John Calipari @CoachCalArk]

Can coaches win Emmys???

Thanks for inviting me @SHO_Billions!

[Hisashi Sawada @hisashi_sawada]

https://t.co/487LfQfhZP

[Eric Green @NHGRI_Director]

The genomics workforce in the US has insufficient representation of individuals from many racial and ethnic groups, those with disabilities, and those from disadvantaged backgrounds, as well as women in faculty and leadership positions.

[Nicholas Kristof @NickKristof]

He shoots! He scores!

[Shayan Mohammadmoradi, MS, PhD @MoradiShayan]

the CAROL Act passed through the U.S. House of Representatives. Familiar names were mentioned on the House Floor! @American_Heart @MaryBShep @alan_daugherty @nih_nhlbi. Thankful to be apart of such impactful research group

@RepAndyBarr @thehill @ResearchKY @atvbahajournals

[UK HealthCare @UK_HealthCare]

“I’m very honored and humbled... It should be shared with the entire sports-medicine team at the University of Kentucky."

Dr. Robert Hosey, who has worked at UK since 1998, named SEC Team Physician of the Year.

https://t.co/9IKAkJhoZD

[Mary B Sheppard, MD @MaryBShep]

@GroupLaakkonen @JeffChenster @honglu227 @hisashi_sawada @alan_daugherty Main benefits include possibility of improved efficacy compared to standard of care as well as long half-life and parenteral administration (such as subcutaneous injection). We have not identified any significant risks to date.

[Mary B Sheppard, MD @MaryBShep]

@GroupLaakkonen @JeffChenster @honglu227 @hisashi_sawada @alan_daugherty Mice have tolerated the ASO very well- no side effects observed so far.